• Explore /
  • Poster
  • / VERTU: Veliparib, radiotherapy (RT) and temozolomide (TMZ) trial in unmethylated MGMT glioblastoma (GBM).

VERTU: Veliparib, radiotherapy (RT) and temozolomide (TMZ) trial in unmethylated MGMT glioblastoma (GBM).

Abstract Poster

Authors

Mustafa Khasraw

Mustafa Khasraw

NHMRC CTC, The University of Sydney, Camperdown NSW, Australia

Mustafa Khasraw , Kerrie Leanne McDonald , Mark Rosenthal , Zarnie Lwin , David M. Ashley , Helen Wheeler , Elizabeth Barnes , Eng-Siew Koh , Matthew C Foote , Michael Buckland , Renee Swanson , Merryn Hall , Sonia Yip , Martinus Oostendorp , John Simes

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Central Nervous System Tumors

Clinical Trial Registration Number

ACTRN12615000407594

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS2081)

DOI

10.1200/JCO.2016.34.15_suppl.TPS2081

Abstract #

TPS2081

Poster Bd #

266b

Abstract Disclosures

Similar Posters

First Author: Anthony J. Chalmers

First Author: Lawrence Kleinberg

First Author: Dinu Stefan

First Author: Matthias Holdhoff